(IDYA) – Corporate News
-
IDEAYA Biosciences (IDYA) Selects Move-Forward Phase 2 Expansion Dose for IDE397
-
IDEAYA Biosciences (IDYA) to Evaluate IDE161 in Combination with KEYTRUDA
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to IDYA Stock Lookup